Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Global Cancer Genome Sequencing Market 2016: Industry Demand, Segment, Consumption and Research to 2022

Thursday, September 22, 2016 2:36
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Latest industry research report on Cancer genome sequencing refers to a method used to identify the complete DNA or RNA sequence of cancer cells based on the sequencing of a single, homogeneous or heterogeneous group of tumor cells. It is a laboratory technique that characterizes DNA or RNA sequences of primary tumor tissue, the tumor micro environment (such as stromal / fibroblast cells), adjacent or distal normal tissue, or metastatic tumor sites. This technique generates information related to identification of nucleotide bases (DNA or RNA), mutation status, copy number and sequence variants, as well as structural variations including fusion genes and chromosomal translocations. This technique has proved to be a breakthrough in the fight against cancer as it assists in individualization of treatment.

Development of new methods and exponential decrease in genome sequencing cost are fueling the market growth. Global cancer genome sequencing market is expected grow with a healthy CAGR due to technological advances and entry of new market players. Agilent Technologies, GE Healthcare Life Sciences, Johnson & Johnson, LI-COR Biosciences (Lincoln, NE), Abbott Laboratories, Beckman Coulter (Fullerton, CA), Bayer Corporation, Hamilton Thorne Biosciences, Integrated DNA Technologies, Microchip Biotechnologies, Myriad Genetics, Commonwealth Biotechnologies, ZS Genetics, and Pacific Biosciences are some of the key players of this market.

Get Free Sample Report Of Cancer Genome Sequencing Market :http://www.marketresearchstore.com/report/world-cancer-genome-sequencing-market-opportunities-and-68564#RequestSample

The global cancer genome sequencing market is segmented on the basis of technology and geography. The currently technologies used include second generation and third generation platforms. Second generation technology platforms include SOLiD sequencing (by ABI), Pyro-sequencing (by Roche) and Bridge amplification sequencing technology (by Illumina). Third generation technology platform includes Single Molecule Real Time (SMRT) sequencing (by Pacific Biosciences), Ion semiconductor sequencing, Nanopore sequencing (by Oxford) and fluorescent resonant energy transfer (FRET) sequencing (by VisiGen biotechnologies).

Geographically, the global cancer genome sequencing market is segmented into North America, Europe, Asia-Pacific and LAMEA. North America dominates the global cancer genome sequencing market due to availability of advanced technologies and a skilled workforce. This market is driven by whole genome sequencing coupled with bioinformatics based sequencing technologies which provide personalized treatments for cancer.

Have Any Query? Ask Our Expert @http://www.marketresearchstore.com/report/world-cancer-genome-sequencing-market-opportunities-and-68564#InquiryForBuying

 KEY BENEFITS

This report offers the following benefits in particular:

  • Pin-point analysis of geographic segments helps to identify opportunities for growth within the global cancer genome sequencing market
  • Porter’s Five Forces analysis examines the competitive structure of the global cancer genome sequencing market and would assist market strategists in their decision-making process.
  • In-depth coverage of the global cancer genome sequencing market including drivers, restraints and opportunities would help professionals to better understand market behavior
  • Detailed study of the strategies of key leaders, partnerships and acquisitions in the global cancer genome sequencing market would be informative for professionals in the corporate sector
  • KEY MARKET SEGMENTS The global cancer genome sequencing market is segmented into two broad categories: technology and geography.

MARKET BY TECHNOLOGY

  • Second Generation Technology Platforms
  • SOLiD sequencing (by ABI)
  • Pyro-sequencing (by Roche)
  • Bridge amplification sequencing technology (by Illumina)
  • Third Generation Technology Platforms
  • Single Molecule Real Time (SMRT) sequencing (by Pacific Biosciences)
  • Ion semiconductor sequencing.
  • Nanopore sequencing (by Oxford)
  • fluorescent resonant energy transfer (FRET) sequencing (by VisiGen biotechnologies)

MARKET BY GEOGRAPHY

  • North America
  • Europe
  • Asia-Pacific
  • LAMEA

About Market Research Store

Market Research Store is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations. Market Research Store is the comprehensive collection of market intelligence products and services available on air. We have market research reports from number of leading publishers and update our collection daily to provide our clients with the instant online access to our database. With access to this database, our clients will be able to benefit from expert insights on global industries, products, and market trends.

Contact Us:

Joel John
3422 SW 15 Street, Suit #8138,
Deerfield Beach, Florida 33442,
United States
Tel: +1-386-310-3803
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No. 1-855-465-4651
Email: sales@marketresearchstore.com
Web: http://www.marketresearchstore.com/

 

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.